A solution for drug loss in Japan
Japanese genomic information is key to P1 data acceptance for overseas trials. The potential for clinical trial cost reduction and drug loss elimination to be achieved through the use of information from the Tohoku Medical Megabank should be highlighted.
https://miyata-bio.net/column/0000339/
この記事が気に入ったらサポートをしてみませんか？